How much debt does Cryo-Cell International have?

Cryo-Cell International had total debt of $10.47M as of Nov 30, 2025, against $3.30M in cash and short-term investments. Total debt was $12.93M a year earlier.

What are Cryo-Cell International's total assets?

Cryo-Cell International reported total assets of $61.73M as of Nov 30, 2025, down 4.6% from $64.68M a year earlier. Total liabilities were $80.33M.

What is Cryo-Cell International's shareholders' equity?

Cryo-Cell International's shareholders' equity was negative at −$18.61M as of Nov 30, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry.

Cryo-Cell International (CCEL) Balance Sheet: Assets & Liabilities

Cryo-Cell International Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cryo-Cell International, Inc. (CCEL) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Nov 2025	Feb 2025	Nov 2024	Nov 2023	Feb 2023	Nov 2022	Nov 2021	Nov 2020	Nov 2019	Nov 2018	Nov 2017
Current Assets
Cash and Cash Equivalents	0.32	0.56	0.56	0.41	1.70	1.70	8.26	10.36	6.54	6.04	6.28
Short-Term Investments	2.98	2.94	2.94	0.57	0.02	0.02	0.08	0.09	0.90	0.88	0.44
Cash & Short-Term Investments	3.30	3.50	3.50	1.10	1.72	1.72	8.34	10.45	7.45	6.92	6.72
Accounts Receivable	6.85	7.31	7.31	6.58	6.04	6.04	5.25	6.32	6.10	5.87	5.13
Inventory	0.41	0.66	0.66	0.77	0.85	0.85	0.92	0.93	1.08	16.04	0.31
Other Current Assets	1.21	1.09	0.45	1.13	0.99	0.43	0.71	0.61	0.76	0.72	0.58
Total Current Assets	11.76	12.55	12.55	9.45	9.61	9.61	15.78	18.56	15.39	29.54	12.74
Non-Current Assets
Property, Plant & Equipment (Net)	21.85	22.70	22.70	22.03	14.21	14.21	4.15	1.94	1.85	1.49	0.88
Long-Term Investments	0.00	0.00	-	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.00
Goodwill	1.94	1.94	1.94	1.94	1.94	1.94	1.94	1.94	1.94	1.94	0.00
Intangible Assets	0.86	0.92	0.92	0.99	15.15	15.15	16.21	1.53	1.25	1.34	0.23
Other Non-Current Assets	24.54	5.76	5.76	26.50	9.92	9.92	10.26	11.56	13.07	0.11	0.03
Total Non-Current Assets	49.97	52.12	52.12	51.77	55.28	55.28	44.88	27.64	27.50	12.85	11.17
Total Assets	61.73	64.68	64.68	61.22	64.89	64.89	60.66	46.20	42.89	42.39	23.91
Current Liabilities
Accounts Payable	2.87	1.88	1.88	3.17	1.61	1.61	1.49	0.96	1.37	1.26	1.93
Short-Term Debt	2.30	4.12	3.69	1.22	2.72	2.42	1.90	3.10	3.10	0.00	0.00
Current Portion of Long-Term Debt	0.18	-	0.17	0.17	-	0.15	1.90	3.10	-	-	-
Accrued Liabilities	4.28	-	4.39	5.17	-	3.24	3.06	1.94	-	-	-
Deferred Revenue	9.73	9.79	9.79	9.70	9.59	9.59	9.36	9.18	8.88	8.37	7.43
Other Current Liabilities	4.28	4.39	-	1.20	5.23	1.98	4.96	1.94	1.91	5.48	4.23
Total Current Liabilities	19.79	21.60	21.60	20.86	19.48	19.48	21.07	16.41	15.43	15.43	13.94
Non-Current Liabilities
Long-Term Debt	8.17	8.82	8.31	8.43	8.89	8.58	0.61	2.84	0.00	0.00	0.00
Other Non-Current Liabilities	51.90	0.92	0.92	42.11	2.04	2.04	3.52	2.38	10.78	15.55	6.72
Total Non-Current Liabilities	60.54	56.29	56.29	51.39	46.93	46.93	35.40	32.45	34.41	35.87	22.47
Total Liabilities	80.33	77.89	77.89	72.25	66.41	66.41	56.48	48.87	49.84	51.30	36.41
Stockholders' Equity
Common Stock	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.14	0.14	0.14	0.13
Retained Earnings	-38.44	-32.78	-32.78	-31.16	-21.64	-21.64	-16.74	-18.82	-22.44	-25.33	-24.47
Accumulated Other Comprehensive Income	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.34	0.04
Treasury Stock	25.03	-	24.86	23.43	-	22.63	20.81	-	-	-	-
Additional Paid-in Capital	19.68	19.41	44.27	19.98	19.96	42.60	41.59	16.02	15.36	15.94	11.80
Shares Outstanding	8.06	-	8.08	8.29	-	8.50	8.56	-	-	-	-
Total Stockholders' Equity	-18.61	-13.22	-13.22	-11.03	-1.52	-1.52	4.18	-2.67	-6.95	-8.91	-12.50
Total Liabilities & Equity	61.73	64.68	64.68	61.22	64.89	64.89	60.66	46.20	42.89	42.39	23.91

Source: Company financial statements from annual and quarterly filings. Data as of Aug 31, 2026. Data sources and methodology

Cryo-Cell International Balance Sheet Analysis

Frequently Asked Questions About Cryo-Cell International Balance Sheet